LiveNow Longevity Review

What LiveNow Longevity charges

LiveNow Longevity does not publish a price today.

LiveNow Longevity also sells 2 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider) and TB-500 (board ranks no provider).

Cancellation, refunds and shipping

What LiveNow Longevity states on its own site about leaving, getting money back, and what delivery costs. Read on September 2026.

• StatedCancellation: A 24-hour window on the booking fee, and the booking runs on someone else's platform: "the new-patient evaluation is charged at the time of booking and is refundable up to 24 hours before your scheduled visit." The Terms note that "Appointment scheduling and payment processing are provided by third-party platforms (including Carepatron and its payment processors). Their terms and privacy policies govern those services" — so the cancellation mechanics sit partly outside this seller's published terms.
• StatedRefund: The only refund term published is the one attached to the booking: the $88 new-patient evaluation "is refundable up to 24 hours before your scheduled visit." Nothing is published about medication, which the homepage says is "billed separately at pharmacy pass-through cost", or about ongoing management. "Refund" appears zero times in the 15,435 characters of homepage text.
• Not statedShipping: Zero occurrences of "shipping" in the 15,435 characters of homepage text and zero in the 5,805-character Terms. Medication is billed "at pharmacy pass-through cost" with no shipping cost, window or carrier published anywhere.

Who prescribes

Whether LiveNow Longevity identifies the clinician or medical practice behind the prescription, or describes them only as a group. Read on September 2026.

• NamedLiveNow Longevity names the clinician or medical practice responsible for prescribing.

It explains the trick the rest of the market runs on

The essay says a research-use-only label is not a safety warning. It is a legal framing that lets a seller move a product as a laboratory chemical rather than a medication, sidestepping the prescription and drug requirements a medication has to meet.

It says plainly that the disclaimer protects the seller and does nothing for the person injecting the product. If you are weighing a research-chemical vendor against a clinic, that is the paragraph to read first.

It then prints a table of structural red flags, each one a sign that a source is operating in the gray market rather than the clinical pathway. It states outright that it is making no claim about any particular seller.

It also explains what lawful compounding is, by section, and what that framework demands around sterility, labeling and record-keeping.

It talks its own product down

On the tissue-repair peptide's own product page, the clinic says the evidence is mostly preclinical and the compound is not an approved drug. It adds that the peptide is not a first-line treatment and not a substitute for proven care.

That is a seller telling you, on the page selling the thing, that the case for it is weak. It is not common anywhere in this market.

The page also says the compound is used only under physician supervision, as a compounded preparation, and should not be bought from an online research-use-only vendor. That is the essay's argument, turned on its own product.

Every figure on the site buys an appointment

Fourteen dollar amounts appear across the two pages, and all fourteen are the same evaluation fee, which sits in the sitewide navigation and repeats on every page.

The clinic's own answer to what a peptide costs is that you start with a physician evaluation, applied toward the protocol if you continue. No medication figure follows it, and even the dedicated cost page prints nothing else.

So you can find out what the appointment costs and nothing more. Ask for the protocol figure at that appointment.

No company is named anywhere. The identity behind the clinic is a named, board-certified physician whose credentials are published as images.

Who LiveNow Longevity suits

Strengths and trade-offs

How we verified this

• The research-use-only essay and the product page were read as a visitor sees them, in September 2026.
• All fourteen dollar amounts across those two pages are the same evaluation fee.
• The clinic's own answer to its cost question ends at the evaluation fee, with no medication figure following it.
• The essay argues against the research-use-only label rather than relying on it, and says it makes no claim about any specific seller.
• The physician's credential images are reachable and are credentials, not certificates of analysis.
• The trading name was checked against the federal warning-letter database in September 2026.